Pharmafile Logo
Pharmafocus logo
Advanced Search

Foundation status offered to 38 more trusts

October 31, 2003

A further 38 hospital have been invited to apply for foundation trust status after winning three stars in the recent …

News

Doubts over pipeline cloud Aventis results

October 31, 2003

Aventis may struggle to replace revenue from its ageing blockbusters despite a strong performance in the second quarter, according to …

News

BMS and Lilly exceed expectations

October 31, 2003

Strong sales of established and new products in the second quarter saw both Bristol-Myers Squibb and Eli Lilly beat analysts' …

News

Smooth transition from old to new for AstraZeneca

October 31, 2003

Growth in new products are helping to plug the sizeable gap left by three of AstraZeneca's ageing blockbusters Prilosec (Losec), …

News

Weak dollar contains Sanofi growth

October 31, 2003

The weakness of the US dollar more than halved Sanofi-Synthelabo's earnings in the first half of this year, but disguised …

News

Heart failure guidelines recommend ACE inhibitors

October 31, 2003

ACE inhibitors have been recommended as first line treatment for chronic heart failure as part of a comprehensive set of …

News

Media training company launched

October 31, 2003

A new training agency specialising in preparing pharmaceutical spokespeople to deal with modern media techniques has been launched.Asparagus Media, set …

News

Industry could gain access to yellow card data

October 31, 2003

The pharmaceutical industry could be granted access to data from the UK's Yellow Card adverse effect warning system to assist …

News

Celebrex to gain orphan drug indication

October 31, 2003

Pfizer's blockbuster arthritis drug Celebrex is set to gain a European orphan drug licence for the treatment of a rare …

News

Challenging second quarter for big pharma

October 31, 2003

Generic competition and wholesaler de-stocking are among the problems besetting two of the industry's biggest hitters, GlaxoSmithKline and AstraZeneca.Deutsche Bank …

News

NICE suspends breast cancer appraisal to await data

October 31, 2003

News

NHS leaders pour scorn on star ratings

October 31, 2003

New star ratings for all NHS trusts have been attacked by leaders in primary and secondary care, who say they …

News

PCTs to hold balance of power in community pharmacy

October 31, 2003

Pharmacy leaders have welcomed plans to protect local pharmacies from greater competition, but say crucial detail must now be agreed …

News

Breakthrough in consultant contract talks

October 31, 2003

Doctors' leaders have declared a breakthrough in the long-running and bitter dispute over the new consultants' contract.The halving of the …

News

Seroxat safety review widens

October 31, 2003

News

GlaxoSmithKline announce Indian partnership

October 29, 2003

News

PR heavyweights launch new agency

October 29, 2003

Former managing directors of Shire Health London and Cohn & Wolfe Healthcare have joined forces to launch a new independent, …

News

New R&D chief as Merck files Erbitux

October 29, 2003

German pharmaceutical Merck KgaA has appointed a new head of clinical research and development following a major R&D re-organisation. Dr …

News

Liver test takes shine off Exanta

October 29, 2003

AstraZeneca has admitted that patients on its new anti-clotting drug Exanta will need liver tests, denting the drug's profile as …

News

US approval for breakthrough diabetes device

October 29, 2003

The first integrated glucose meter and insulin pump has been approved by the FDA, bringing the goal of an 'artificial …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025